glp-1 for chronic pain and its derived peptides mediate relief through direct TRPV1 inhibition without affecting thermoregulation GLP-1 and GIP: Magic bullet

Making unclear that their drugs are untested and unregulated might lead to potential harm. The researchers hope their findings inform regulatory policy changes for compounded drugs advertising to protect consumers, said Joseph Ross, MD, MHS, professor of medicine (general medicine) at YSM and of public health (health policy and management) at the Yale School of Public Health and a member of the team

USA 105 , 877882 (2008) Lebon, G

That is why, as with any symptom, it is incorrect to treat only the restless leg syndrome rather than the condition responsible for it

Dosing errors are the most commonly reported issue

Reference: [1]Huang, KP., Acosta, A.A., Ghidewon, M.Y

[DOI] [PMC free article] [PubMed] [Google Scholar] 58.Packer M